GTBP Stock Analysis: Buy, Sell, or Hold?
GTBP - GT Biopharma Inc. Common Stock
$0.32
0.02 (6.35%)
▲
5d:
+9.06%
30d:
-28.42%
90d:
-17.82%
HOLD
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026
3d
Get Alerted When GTBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GTBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GTBP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GTBP is currently trading at $0.32, which is considered slightly low relative to its 30-day fair value range of $0.31 to $0.44.
Technical Outlook: Technically, GTBP is showing sideways momentum. Immediate support is located at $0.28, while resistance sits at $0.34. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: GTBP has a strong technical setup (97/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+837.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GTBP is showing sideways momentum. Immediate support is located at $0.28, while resistance sits at $0.34. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: GTBP has a strong technical setup (97/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.00 (+837.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.31 -
$0.44
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (97/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 837.2% below Wall St target ($3.00)
- CAUTION: Bottoming setup, but lagging the sector by 20% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.31 -
$0.44
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$0.34
Current Trend
Sideways
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.19
Wall Street Target
$3.00
(+837.2%)
Share & Embed Analysis
Last updated: August 08, 2026 10:23 PM ET
Data refreshes hourly during market hours. Next update: 11:23 PM
Data refreshes hourly during market hours. Next update: 11:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GTBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 64 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
